Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

452 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Spatiotemporal Distribution and Molecular Characterization of Circulating Dengue Virus Serotypes/Genotypes in Senegal from 2019 to 2023.
Dieng I, Talla C, Barry MA, Gaye A, Balde D, Ndiaye M, Kane M, Sagne SN, Diagne MM, Diop B, Diallo B, Sall AA, Faye O, Sow A, Fall G, Loucoubar C, Faye O. Dieng I, et al. Among authors: sow a. Trop Med Infect Dis. 2024 Jan 27;9(2):32. doi: 10.3390/tropicalmed9020032. Trop Med Infect Dis. 2024. PMID: 38393121 Free PMC article.
Dengue epidemic in Burkina Faso: how can the response improve?
Manigart O, Ouedraogo I, Ouedraogo HS, Sow A, Lokossou VK. Manigart O, et al. Among authors: sow a. Lancet. 2024 Feb 3;403(10425):434-435. doi: 10.1016/S0140-6736(23)02803-9. Epub 2024 Jan 22. Lancet. 2024. PMID: 38272051 No abstract available.
Rapid On-Site Detection of Arboviruses by a Direct RT-qPCR Assay.
Mhamadi M, Mencattelli G, Gaye A, Ndiaye EH, Sow AA, Faye M, Ndione MHD, Diagne MM, Mhamadi M, Faye O, Weidmann M, Faye O, Diallo M, Diagne CT. Mhamadi M, et al. Among authors: sow aa. Biosensors (Basel). 2023 Dec 16;13(12):1035. doi: 10.3390/bios13121035. Biosensors (Basel). 2023. PMID: 38131795 Free PMC article.
Stigma and infectious diseases in Africa: examining impact and strategies for reduction.
Omosigho PO, John OO, Musa MB, Aboelhassan YMEI, Olabode ON, Bouaddi O, Mengesha DT, Micheal AS, Modber MAKA, Sow AU, Kheir SGM, Shomuyiwa DO, Adebimpe OT, Manirambona E, Lucero-Prisno DE 3rd. Omosigho PO, et al. Among authors: sow au. Ann Med Surg (Lond). 2023 Nov 1;85(12):6078-6082. doi: 10.1097/MS9.0000000000001470. eCollection 2023 Dec. Ann Med Surg (Lond). 2023. PMID: 38098545 Free PMC article. Review.
Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults.
Lee AW, Liu K, Lhomme E, Blie J, McCullough J, Onorato MT, Connor L, Simon JK, Dubey S, VanRheenen S, Deutsch J, Owens A, Morgan A, Welebob C, Hyatt D, Nair S, Hamzé B, Guindo O, Sow SO, Beavogui AH, Leigh B, Samai M, Akoo P, Serry-Bangura A, Fleck S, Secka F, Lowe B, Watson-Jones D, Roy C, Hensley LE, Kieh M, Coller BG; PREVAC Study Team. Lee AW, et al. Clin Infect Dis. 2024 Apr 10;78(4):870-879. doi: 10.1093/cid/ciad693. Clin Infect Dis. 2024. PMID: 37967326 Free PMC article. Clinical Trial.
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.
Choi EM, Lacarra B, Afolabi MO, Ale BM, Baiden F, Bétard C, Foster J, Hamzé B, Schwimmer C, Manno D, D'Ortenzio E, Ishola D, Keita CM, Keshinro B, Njie Y, van Dijck W, Gaddah A, Anumendem D, Lowe B, Vatrinet R, Lawal BJ, Otieno GT, Samai M, Deen GF, Swaray IB, Kamara AB, Kamara MM, Diagne MA, Kowuor D, McLean C, Leigh B, Beavogui AH, Leyssen M, Luhn K, Robinson C, Douoguih M, Greenwood B, Thiébaut R, Watson-Jones D; EBOVAC-3/EBL2005 Study Team. Choi EM, et al. Lancet Glob Health. 2023 Nov;11(11):e1743-e1752. doi: 10.1016/S2214-109X(23)00410-2. Lancet Glob Health. 2023. PMID: 37858585 Free article. Clinical Trial.
452 results